# PhenixFIN Corp: overview PFX · Nasdaq · CIK 1490349 · [Other](/sectors/other.md) · fiscal year ends Sep 30 Pages: [Overview](/companies/pfx.md) · [Financials](/companies/pfx/financials.md) · [Filings](/companies/pfx/filings.md) · [Insiders](/companies/pfx/insiders.md) Revenue is not reported in this company’s XBRL financial statements. ## Last eight quarters | Line item | Unit | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $ | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | not reported | [1.22](/filings/0001213900-26-013689.md) | [(0.44)](/filings/0001213900-26-052253.md) | [(0.74)](/filings/0001213900-26-085667.md) | not reported | [(2.38)](/filings/0001213900-26-013689.md) | [0.57](/filings/0001213900-26-052253.md) | [2.19](/filings/0001213900-26-085667.md) | | Free cash flow | $ | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure. ## Last five fiscal years | Line item | Unit | FY (2021-09-30) | FY (2022-09-30) | FY2023 (2023-09-30) | FY2024 (2024-09-30) | FY2025 (2025-09-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $ | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [0.48](/filings/0001213900-23-098182.md) | [(2.63)](/filings/0001213900-24-109444.md) | [12.87](/filings/0001213900-25-120913.md) | [9.13](/filings/0001213900-25-120913.md) | [2.06](/filings/0001213900-25-120913.md) | | Free cash flow | $ | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/pfx/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [Adalta Capital Management LLC](/funds/1698926.md) | 2026-06-30 | $7.5m | 176,569 | | Added +1,000 | | [AMERICAN FINANCIAL GROUP INC](/funds/1042046.md) | 2026-06-30 | $2.7m | 64,327 | | Unchanged | | [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $2.3m | 54,462 | | Reduced −496 | | [Bulldog Investors, LLP](/funds/1504304.md) | 2026-06-30 | $817.9k | 19,218 | | Unchanged | | [Legal & General Group Plc](/funds/764068.md) | 2026-06-30 | $655.3k | 15,140 | | Unchanged | | [OSAIC HOLDINGS, INC.](/funds/1677044.md) | 2026-06-30 | $17.0k | 400 | | Unchanged | | [Allworth Financial LP](/funds/1555170.md) | 2026-06-30 | $12.2k | 286 | | Unchanged | | [WELLS FARGO & COMPANY/MN](/funds/72971.md) | 2026-06-30 | $10.6k | 250 | | Reduced −1 | | [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $5.5k | 130 | | Reduced −358 | | [IFG Advisory, LLC](/funds/1728319.md) | 2026-06-30 | $298 | 7 | | New +7 | ## Recent filings [All 891 filings](/companies/pfx/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-08-05 | 16:07 ET | [10-Q](/filings/0001213900-26-085667.md) | Quarterly report, period 2026-06-30 | 0001213900-26-085667 | | 2026-08-05 | 16:05 ET | [8-K](/filings/0001213900-26-085661.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-085661 | | 2026-05-14 | 17:41 ET | [SCHEDULE 13D/A](/filings/0001213900-26-056879.md) | Ownership report, active investor, amended | 0001213900-26-056879 | | 2026-05-05 | 16:38 ET | [10-Q](/filings/0001213900-26-052253.md) | Quarterly report, period 2026-03-31 | 0001213900-26-052253 | | 2026-05-05 | 16:35 ET | [8-K](/filings/0001213900-26-052245.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-052245 | | 2026-04-02 | 16:45 ET | [SCHEDULE 13D/A](/filings/0001213900-26-039424.md) | Ownership report, active investor, amended | 0001213900-26-039424 | | 2026-03-20 | 16:02 ET | [8-K](/filings/0001213900-26-032335.md) | 5.07 Shareholder vote results | 0001213900-26-032335 | | 2026-02-09 | 16:32 ET | [10-Q](/filings/0001213900-26-013689.md) | Quarterly report, period 2025-12-31 | 0001213900-26-013689 | | 2026-02-09 | 16:30 ET | [8-K](/filings/0001213900-26-013686.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-013686 | | 2026-01-28 | 16:55 ET | [DEF 14A](/filings/0001213900-26-008903.md) | Proxy statement, period 2026-03-20 | 0001213900-26-008903 | ## Latest annual report [Form 10-K for the fiscal year ended Sep 30, 2025](/filings/0001213900-25-120913.md), filed Dec 12, 2025. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 1490349 - Tickers: PFX, PFXNZ - Exchange: Nasdaq - SIC code: not reported - State of incorporation: DE - Filer category: Non-accelerated filer Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:41 ET. No prices; not investment advice.